Shares of Cardiol Therapeutics Inc. (OTCMKTS:CRTPF – Get Free Report) were down 1.6% during trading on Wednesday . The stock traded as low as $1.21 and last traded at $1.25. Approximately 263,962 shares traded hands during trading, an increase of 293% from the average daily volume of 67,097 shares. The stock had previously closed at $1.27.
Cardiol Therapeutics Stock Performance
The stock’s 50 day simple moving average is $1.51 and its two-hundred day simple moving average is $1.84.
About Cardiol Therapeutics
Cardiol Therapeutics Inc is a clinical-stage biotechnology company that focuses on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its product, CardiolRx, is a pharmaceutically produced extra strength oral cannabidiol formulation that is entering a Phase II/III outcomes study in hospitalized patients testing positive for the COVID-19 virus.
See Also
- Five stocks we like better than Cardiol Therapeutics
- How to Invest in Biotech Stocks
- 4 Social Media Stocks Set to Gain as TikTok Ban Looms
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- How Do Stock Buybacks Affect Shareholders?
- What is the Shanghai Stock Exchange Composite Index?
- JPMorgan Chase & Co. Stock Can Hit $300 This Year
Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
